ESR1-targeted immunologic therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ESR1-targeted immunologic therapy, covering 2025-12-04 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer [Phase 1]